State Dispensing Regulations

New Jersey Physician Dispensing Laws & Regulations

Limited to a 7-day supply, which often makes in-office dispensing impractical.

Allowed with restrictions

Note: PharmaLink has compiled the information below for reference only. State dispensing regulations change frequently and we recommend consulting an attorney or your state medical or pharmacy board with specific questions or to verify your eligibility to dispense.

New Jersey permits physician dispensing but caps the quantity low enough that most practices find it does not support a dispensing program.

The 7-day limit

According to N.J. Admin. Code § 13:35-7.5, physician dispensing in New Jersey is limited to a 7-day supply, which often makes it impractical for practitioners to dispense.

Seven days is more generous than the single-dose limits in the most restrictive states, and it is enough to complete a short course of an antibiotic or a brief analgesic regimen. What it will not support is maintenance therapy or any chronic medication, which is where most dispensing revenue is typically found.

The limit applies to the quantity dispensed rather than to a category of drug, so no formulary choice works around it.

Controlled substances

There are additional restrictions and permitting requirements for controlled substance dispensing on top of the general 7-day cap. A practice considering controls in New Jersey should treat those as a separate analysis rather than assuming the same rules apply.

What this means in practice

For multi-state groups, New Jersey generally behaves like a limited-use state: worth dispensing at for acute, short-course situations where handing the patient medication at the visit genuinely helps, and not worth building a full formulary around.

NJPMP reporting

Prescriptions must be reported to the New Jersey Prescription Monitoring Program no more than one business day after the date the prescription was dispensed, submitted daily through the PMP Clearinghouse.

The reportable scope is broader than controlled substances alone. New Jersey requires reporting for Schedule II through V controlled dangerous substances, human growth hormone, and gabapentin dispensed in or into the state. Enrollment in and use of the NJPMP is required for both prescribers and dispensers of monitored drugs.

Dispensing in New Jersey with PharmaLink

Dispensing medications to your patients offers meaningful benefits: additional practice revenue, better medication adherence, greater convenience for patients, and fewer pharmacy callbacks for your staff. PharmaLink provides the dispensing software, equipment, and support — so most practices can start dispensing within days of completing their application. PharmaLink does not sell, source, or ship medications; your practice purchases those directly from suppliers you select, under your own licenses.

If you plan to dispense controlled substances, PharmaLink's software automatically reports to state PDMPs in all states where we operate.

Start dispensing in New Jersey

Most practices are up and running within days of submitting their application. Talk to a specialist about the right dispensing program for your practice.